Prisys is a CRO company, pioneering in non-human primate (NHP) pharmacology, to provide peri-clinical studies of new drug development. Prisys integrated its proprietary modeling expertise and rich pharmacology experience with top-equipped local clinical hospitals, enabling global pharms to access the latest innovational approaches for more translatable and more efficient advancement of new therapeutics. With the huge unmet needs for more clinical relevance and predictions of human-target specific novel therapeutic strategies, Prisys has been continually developing different NHP models covering the following key disease areas:
•	Inflammatory
•	Autoimmune
•	Cardiovascular 
•	Cerebrovascular
•	Hematology
•	Kidney
•	Liver
•	Lung
•	Ophthalmology
•	OB-GYN
•	Oncology

Contact us at : info@prisysbiotech.com
For more information please visit Website: www.prisysbiotech.com


Biotechnology

Clinical Trials

Therapeutics

Prisys Biotechnologies

The Shanghai office focuses on business development, administration, and scientific leadership to drive organizational growth.

Prisys Biotechnologies

Org chart

Teams

Offices